Navigation Links
Sentillion Receives U.S. Patent for Administering Context Management Systems
Date:4/30/2008

Latest Patent Adds to Company's Extensive Patent Portfolio

ANDOVER, Mass., April 30 /PRNewswire/ -- Sentillion, the company that created healthcare single sign-on (SSO), announced that it has been issued a U.S. patent (6,993,556) for its technology upon which system administration tooling for the company's context management solution is based. Context management automatically synchronizes multiple applications in response to a single user gesture directed at any application using readily identifiable information such as a particular patient, encounter or observation. The patent covers core technology relating to setting up and maintaining context subject data definitions, intervening in context management operations, and providing security functions to protect sensitive context information against tampering by unauthorized users. Sentillion provides context management as part of its clinical workstation solution, Vergence. The invention covered by the patent makes it practical for healthcare organizations to deploy and maintain their Vergence system.

Using the patented technology, Sentillion's customers have been able to configure their Vergence systems to perform extremely sophisticated context management capabilities. For example, at one healthcare organization, using Vergence, if a physician reviews a patient's record in the hospital's primary clinical information system and then needs to evaluate images from the patient's chest CT, the simple click of an icon to open the PACS application presents the exact image desired. If the patient had multiple studies, then each selection made in the clinical information system results in the PACS application automatically displaying the associated image. Without Vergence, the physician might have to search through several screens, enter a patient's name or medical record number, or scroll through multiple studies searching for the desired result.

"For over a decade, Sentillion has been a thought leader in the healthcare industry and created the concept of context management which is now deployed at over 560 healthcare institutions worldwide. In addition to our newly patented administration tooling, Sentillion's innovative Bridge technology makes it possible to non-invasively context-enable any application whether it be Web, Windows or legacy-based. Using Sentillion's tools, healthcare organizations can deploy practical context management solutions that enable all types of caregivers to take full advantage of the many clinical applications that are available to them," said David Fusari, vice president and CTO, Sentillion.

Sentillion's identity and access management solutions are the most widely deployed in healthcare and are used daily by more than 350,000 caregivers in 560 unique hospitals across North America and the United Kingdom, including Eisenhower Medical Center, Great Ormond Street Hospital, Sisters of Mercy Health System, Sharp HealthCare and Texas Children's Hospital. Sentillion's patent portfolio also includes patents issued in the U.S. and in the E.U.

About Sentillion, Inc.

Since 1998, Sentillion has been revolutionizing healthcare IT with award winning, industry recognized identity and access management technology. Sentillion has successfully combined patented technology with a deep understanding of the healthcare industry to deliver the most comprehensive set of solutions for single sign-on, user provisioning, clinical workstations and virtualized remote access. Recently recognized as the number one single sign-on (SSO) vendor in the KLAS Top 20: 2007 Year-End Report, Sentillion is the only identity and access management company whose solutions are used daily by over 350,000 caregivers in leading healthcare organizations across North America and Europe. Sentillion is a privately held company headquartered in Andover, Mass. For more information, visit Sentillion at http://www.sentillion.com.

Contact:

Jennifer Haas

Sentillion

(978) 689-9095 x262

jennifer.haas@sentillion.com


'/>"/>
SOURCE Sentillion
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
2. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
3. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
4. Sentillion Launches Channel Partner Program for Healthcare-Specific Identity & Access Management Solutions
5. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
6. iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion
7. Sentillion Ranked #1 Vendor in KLAS Single Sign-On & Context Management Report
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology: